Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott Thomas Jackson Insider Profile
4 Followers
Scott Thomas Jackson, CEO, Director at Celator Pharmaceuticals, holds 55.00K shares in Spero Therapeutics (Ticker: SPRO), holds 4.50K shares in MacroGenics (Ticker: MGNX), holds 5.25K shares in GlycoMimetics (Ticker: GLYC).
Scott Thomas Jackson Celator Pharmaceuticals (CLPM)CEO, Director
Celator Pharmaceuticals (CLPM)
CEO, Director
Not Ranked
Ranked #36,476 out of 99,335 Corporate Insiders
Scott Thomas Jackson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Scott Thomas Jackson holds in companies
Most Profitable Insider Trade
Stock:
Celator Pharmaceuticals
(CLPM)
(CLPM)
Rating:Informative Buy
Date:Nov 18, 2014 - Nov 18, 2015
Return:-18.90%
The most profitable trade made by Scott Thomas Jackson
Scott Thomas Jackson's Trading History
Celator Pharmaceuticals
Jul 12, 2016
―
Uninformative Sell
9.12M
$3.03M
MacroGenics
May 22, 2024
Director
Uninformative Buy
19.17K
$14.45K
GlycoMimetics
May 27, 2021
Director
Uninformative Buy
―
$1.68K
Spero Therapeutics
May 30, 2024
Director
Uninformative Buy
―
$65.45K
Mural Oncology Plc
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Scott Thomas Jackson's performance on stock
You May Also Like
Scott Thomas Jackson insider profile FAQ
What is the percentage of profitable transactions made by Scott Thomas Jackson?
The percentage of profitable transactions made by Scott Thomas Jackson is ―.
What is the average return per transaction made by Scott Thomas Jackson?
The average return per transaction made by Scott Thomas Jackson is ―.
What stocks does Scott Thomas Jackson hold?
Scott Thomas Jackson holds: CLPM, MGNX, GLYC, SPRO, MURA stocks.
What was Scott Thomas Jackson’s latest transaction?
Scott Thomas Jackson latest transaction was an Uninformative Buy of ―.
What was Scott Thomas Jackson's most profitable transaction?
Scott Thomas Jackson’s most profitable transaction was an Informative Buy of CLPM stock on November 18, 2014. The return on the trade was -18.90%.
What is Scott Thomas Jackson's role in Celator Pharmaceuticals?
Scott Thomas Jackson's role in Celator Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.